HCPCS Level II
J1611
Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
Codes near J1611
These sit next to J1611 in the CMS Level II file. All J codes
- J1598Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
- J1599Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
- J1600Injection, gold sodium thiomalate, up to 50 mg
- J1602Injection, golimumab, 1 mg, for intravenous use
- J1610Injection, glucagon hydrochloride, per 1 mg
- J1612Injection, glucagon (gvoke), 0.01 mg
- J1620Injection, gonadorelin hydrochloride, per 100 mcg
- J1626Injection, granisetron hydrochloride, 100 mcg
- J1627Injection, granisetron, extended-release, 0.1 mg
- J1628Injection, guselkumab, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 63323-0582-82 | Glucagon Emergency | FreseniUS Kabi USA, LLC | 1 |
| 63323-0593-03 | Glucagon | FreseniUS Kabi USA, LLC | 1 |
| 63323-0594-03 | Glucagen | FreseniUS Kabi USA, LLC | 1 |
| 63323-0596-13 | Glucagon | FreseniUS Kabi USA, LLC | 10 |
| 63323-0596-16 | Glucagon | FreseniUS Kabi USA, LLC | 10 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.